Applied Therapeutics settles securities fraud class action lawsuit.

Applied Therapeutics, a pharmaceutical company, has reached a settlement in a securities fraud class action lawsuit. The lawsuit alleges that certain officers and directors breached their fiduciary duties. If you purchased Applied Therapeutics shares before January 3, 2024, and still hold shares, you may be eligible for corporate reforms, the return of funds, and an incentive award with no cost to you. Contact Joshua Grabar at jgrabar@grabarlaw.com or 267-507-6085 for more information.

Applied Therapeutics Inc. (NASDAQ: APLT), a pharmaceutical company, has reached a settlement in a securities fraud class action lawsuit. The settlement, announced on August 25, 2025, resolves allegations that certain officers and directors breached their fiduciary duties. The lawsuit alleged that the company made false and misleading statements about its Phase III INSPIRE trial, leading to artificially inflated share prices Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf^[1].

Shareholders who purchased Applied Therapeutics shares before January 3, 2024, and still hold them today are eligible for corporate reforms, the return of funds, and a court-approved incentive award. The process is free of cost to the shareholders. Interested parties are encouraged to visit the Grabar Law Office website , contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 for more information.

The settlement follows a federal securities fraud class action complaint filed against the company, which alleged that Applied Therapeutics provided positive statements to investors while concealing material adverse facts about the INSPIRE trial. These included electronic data capture issues and a dosing error in the dose-escalation phase of the study.

The settlement agreement is subject to court approval and is expected to provide relief to affected shareholders. The company has not admitted liability as part of the settlement. The Grabar Law Office is currently investigating similar claims on behalf of shareholders of other companies, including Elevance Health Inc. (NYSE: ELV), LifeMD, Inc. (NASDAQ: LFMD), and Quantum Corporation (NASDAQ: QMCO) .

Shareholders are advised to review the settlement terms carefully and consult with a legal professional if they have questions about their eligibility or the settlement process. The settlement is a significant step towards addressing the allegations and providing potential relief to affected shareholders.